Autolus Therapeutics (AUTL) FCF Margin (2017 - 2025)
Autolus Therapeutics' FCF Margin was -273.53% in Q4 2025, up 168850.61 percentage points from -169124.14% a year earlier and up 67.64 percentage points from the prior quarter.
Powered by 
Analysis
Autolus Therapeutics (AUTL) FCF Margin (2017 - 2025) Analysis & Trends
For FY2025, FCF Margin at Autolus Therapeutics came in at -401.40%, up 1854.98 percentage points from FY2024.
- FCF Margin shows a five-year change of +7320.99 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -2256.38% in FY2024 (+6964.64 pp), -9221.02% in FY2023 (-7284.72 pp), -1936.31% in FY2022 (+3502.24 pp) and -5438.54% in FY2021 (+2283.85 pp).
- The Q4 2025 figure marks the highest quarterly FCF Margin in data going back to Q1 2018.
- The best year-over-year quarter for FCF Margin over five years was Q4 2025 (a gain of 168850.61 percentage points); the worst was Q3 2021 (a drop of 11461.19 percentage points).
- Per Business Quant data, AUTL's FCF Margin in the three quarters before Q4 2025 was -341.17% (Q3 2025), -382.63% (Q2 2025) and -933.07% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Autolus Therapeutics | 660.38 Mn | -663.71 Mn | 25.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -273.53% |
| Sep 30, 2025 | -341.17% |
| Jun 30, 2025 | -382.63% |
| Mar 31, 2025 | -933.07% |
| Dec 31, 2024 | -169,124.14% |
| Mar 31, 2024 | -406.77% |
| Sep 30, 2023 | -10,267.49% |
| Mar 31, 2023 | -3,563.54% |
| Dec 31, 2022 | -397.36% |
| Sep 30, 2022 | -1,633.64% |
| Mar 31, 2022 | -21,566.87% |
| Dec 31, 2021 | -5,968.33% |
| Sep 30, 2021 | -16,360.17% |
| Jun 30, 2021 | -2,317.45% |
| Mar 31, 2021 | -14,588.48% |
| Dec 31, 2020 | -16,275.49% |
| Sep 30, 2020 | -4,898.98% |
| Jun 30, 2020 | -10,053.24% |
| Mar 31, 2020 | -7,890.53% |
| Mar 31, 2019 | -1,723.37% |
API Access
Autolus Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();